Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program
Fanikos, J.; Murwin, D.; Gruenenfelder, F.; Tartakovsky, I.; França, L. R.; Reilly, P. A. & Kermer, P. et al. (2020)
Thrombosis and Haemostasis, 120(01) pp. 027-035. DOI: https://doi.org/10.1055/s-0039-1695771
